L'intérêt à découvert pour Alibaba Gr Hldgs donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Alibaba Gr Hldgs. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Alibaba Gr Hldgs (OTC:BABAF) Stock, Rapport sur les intérêts à découvert

Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

Alibaba Group Holding Ltd

<p><strong>WEX</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEX#NYSE">WEX</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that WEX will report an <strong>earnings per share</strong> (EPS) of $3.44. </p>
<p>Anticipation surrounds WEX's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.11, which was followed by a 6.85% drop in the share price the next day.</p>
<p>Here's a look at WEX's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.40</td>
<td>3.55</td>
<td>4.42</td>
<td>3.80</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.51</td>
<td>3.57</td>
<td>4.35</td>
<td>3.91</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>-19.0%</td>
<td>-1.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210979_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of WEX were trading at $154.18 as of July 21. Over the last 52-week period, shares are down 10.13%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Observations about WEX</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding WEX.</p>
<p>The consensus rating for WEX is Neutral, derived from 4 analyst ratings. An average one-year price target of $140.75 implies a potential 8.71% downside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Shift4 Payments, Sezzle and Euronet Worldwide, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Shift4 Payments, with an average 1-year price target of $114.8, suggesting a potential 25.54% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Sezzle, with an average 1-year price target of $185.0, suggesting a potential 19.99% upside.</li>
<li>Analysts currently favor an Buy trajectory for Euronet Worldwide, with an average 1-year price target of $122.33, suggesting a potential 20.66% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Shift4 Payments, Sezzle and Euronet Worldwide, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>WEX</td>
<td>Neutral</td>
<td>-2.47%</td>
<td>$366.60M</td>
<td>6.22%</td>
</tr>
<tr>
<td>Shift4 Payments</td>
<td>Outperform</td>
<td>19.92%</td>
<td>$257M</td>
<td>2.07%</td>
</tr>
<tr>
<td>Sezzle</td>
<td>Outperform</td>
<td>123.32%</td>
<td>$74.55M</td>
<td>33.86%</td>
</tr>
<tr>
<td>Euronet Worldwide</td>
<td>Buy</td>
<td>6.83%</td>
<td>$354.50M</td>
<td>3.03%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>WEX ranks at the bottom for Revenue Growth with a negative rate, while its peers show positive growth rates. In terms of Gross Profit, WEX is at the top among its peers. However, WEX has the lowest Return on Equity compared to its peers. Overall, WEX's performance is mixed when compared to its peers in these key financial metrics.</p>
<h3>Unveiling the Story Behind WEX</h3>
<p>WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.</p>
<h3>WEX: A Financial Overview</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> WEX's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately <strong>-2.47%</strong>. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> WEX's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>11.23%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>6.22%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> WEX's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.52%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>6.89</strong>, WEX faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/WEX/earnings"><strong>To track all earnings releases for WEX visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Examining the Future: WEX's Earnings Outlook

<p>First American Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-23. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect First American Financial to report an <strong>earnings per share</strong> (EPS) of $1.42.</p>
<p>Anticipation surrounds First American Financial's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.19 in the last quarter, leading to a 4.86% increase in the share price on the following day.</p>
<p>Here's a look at First American Financial's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.65</td>
<td>1.09</td>
<td>1.14</td>
<td>1.16</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.84</td>
<td>1.35</td>
<td>1.34</td>
<td>1.27</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>5.0%</td>
<td>0.0%</td>
<td>0.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210970_0.png" alt="eps graph" /></p>
<h3>First American Financial Share Price Analysis</h3>
<p>Shares of First American Financial were trading at $56.43 as of July 21. Over the last 52-week period, shares are up 0.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/FAF/earnings"><strong>To track all earnings releases for First American Financial visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from First American Financial's Earnings

<p>Wyndham Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WH#NYSE">WH</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Wyndham Hotels &amp; Resorts will report an <strong>earnings per share</strong> (EPS) of $1.16.</p>
<p>Wyndham Hotels &amp; Resorts bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.05 in the last quarter, leading to a 0.07% increase in the share price on the following day.</p>
<p>Here's a look at Wyndham Hotels &amp; Resorts's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.81</td>
<td>0.99</td>
<td>1.38</td>
<td>1.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.86</td>
<td>1.04</td>
<td>1.39</td>
<td>1.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-2.0%</td>
<td>11.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210960_0.png" alt="eps graph" /></p>
<h3>Performance of Wyndham Hotels &amp; Resorts Shares</h3>
<p>Shares of Wyndham Hotels &amp; Resorts were trading at $85.73 as of July 21. Over the last 52-week period, shares are up 23.8%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WH/earnings"><strong>To track all earnings releases for Wyndham Hotels &amp; Resorts visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look at Wyndham Hotels & Resorts's Upcoming Earnings Report

<p>Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Selective Insurance Gr will report an <strong>earnings per share</strong> (EPS) of $1.53.</p>
<p>The market awaits Selective Insurance Gr's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS missed by $0.10 in the last quarter, leading to a 1.8% drop in the share price on the following day.</p>
<p>Here's a look at Selective Insurance Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.86</td>
<td>1.99</td>
<td>1.65</td>
<td>1.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.76</td>
<td>1.62</td>
<td>1.40</td>
<td>-1.10</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-13.0%</td>
<td>-4.0%</td>
<td>-18.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210949_0.png" alt="eps graph" /></p>
<h3>Performance of Selective Insurance Gr Shares</h3>
<p>Shares of Selective Insurance Gr were trading at $88.59 as of July 21. Over the last 52-week period, shares are up 3.68%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SIGI/earnings"><strong>To track all earnings releases for Selective Insurance Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SIGI

Earnings Outlook For Selective Insurance Gr

<p><strong>Mattel</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Mattel will report an <strong>earnings per share</strong> (EPS) of $0.17. </p>
<p>The market awaits Mattel's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.07 in the last quarter, leading to a 2.78% increase in the share price on the following day.</p>
<p>Here's a look at Mattel's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.10</td>
<td>0.20</td>
<td>0.95</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.35</td>
<td>1.14</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>15.0%</td>
<td>4.0%</td>
<td>10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210930_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Mattel were trading at $19.88 as of July 21. Over the last 52-week period, shares are up 5.94%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Mattel</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Mattel.</p>
<p>With 5 analyst ratings, Mattel has a consensus rating of Buy. The average one-year price target is $22.8, indicating a potential 14.69% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Acushnet Holdings, Brunswick and YETI Holdings, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Acushnet Holdings, with an average 1-year price target of $74.2, suggesting a potential 273.24% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Brunswick, with an average 1-year price target of $56.2, suggesting a potential 182.7% upside.</li>
<li>Analysts currently favor an Outperform trajectory for YETI Holdings, with an average 1-year price target of $38.67, suggesting a potential 94.52% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Acushnet Holdings, Brunswick and YETI Holdings, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mattel</td>
<td>Buy</td>
<td>2.11%</td>
<td>$408.10M</td>
<td>-1.84%</td>
</tr>
<tr>
<td>Acushnet Holdings</td>
<td>Neutral</td>
<td>-0.59%</td>
<td>$337.16M</td>
<td>12.86%</td>
</tr>
<tr>
<td>Brunswick</td>
<td>Neutral</td>
<td>-10.49%</td>
<td>$303.90M</td>
<td>1.07%</td>
</tr>
<tr>
<td>YETI Holdings</td>
<td>Outperform</td>
<td>2.85%</td>
<td>$201.72M</td>
<td>2.21%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Mattel ranks at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. However, it ranks at the top for Return on Equity.</p>
<h3>Unveiling the Story Behind Mattel</h3>
<p>Mattel manufactures and markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas &amp; Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.</p>
<h3>Key Indicators: Mattel's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Mattel's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>2.11%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Mattel's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-4.88%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Mattel's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-1.84%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Mattel's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-0.63%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Mattel's debt-to-equity ratio surpasses industry norms, standing at <strong>1.26</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<p><a href="https://www.benzinga.com/quote/MAT/earnings"><strong>To track all earnings releases for Mattel visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Mattel's Upcoming Earnings

<p>Sonoco Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SON#NYSE">SON</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-23. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Sonoco Prods to report an <strong>earnings per share</strong> (EPS) of $1.47.</p>
<p>The market awaits Sonoco Prods's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.03, which was followed by a 12.32% drop in the share price the next day.</p>
<p>Here's a look at Sonoco Prods's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.41</td>
<td>1.2</td>
<td>1.45</td>
<td>1.25</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.38</td>
<td>1</td>
<td>1.49</td>
<td>1.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-12.0%</td>
<td>-4.0%</td>
<td>-3.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210916_0.png" alt="eps graph" /></p>
<h3>Tracking Sonoco Prods's Stock Performance</h3>
<p>Shares of Sonoco Prods were trading at $46.03 as of July 21. Over the last 52-week period, shares are down 7.59%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Sonoco Prods</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Sonoco Prods.</p>
<p>The consensus rating for Sonoco Prods is Outperform, derived from 4 analyst ratings. An average one-year price target of $52.75 implies a potential 14.6% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Sealed Air, Graphic Packaging Holding and Ranpak Hldgs, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Sealed Air, with an average 1-year price target of $39.33, suggesting a potential 14.56% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Graphic Packaging Holding, with an average 1-year price target of $25.0, suggesting a potential 45.69% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Ranpak Hldgs, with an average 1-year price target of $5.5, suggesting a potential 88.05% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Sealed Air, Graphic Packaging Holding and Ranpak Hldgs are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sonoco Prods</td>
<td>Outperform</td>
<td>30.61%</td>
<td>$353.69M</td>
<td>2.31%</td>
</tr>
<tr>
<td>Sealed Air</td>
<td>Buy</td>
<td>-4.29%</td>
<td>$391.70M</td>
<td>15.96%</td>
</tr>
<tr>
<td>Graphic Packaging Holding</td>
<td>Neutral</td>
<td>-6.15%</td>
<td>$445M</td>
<td>4.12%</td>
</tr>
<tr>
<td>Ranpak Hldgs</td>
<td>Neutral</td>
<td>6.92%</td>
<td>$30.90M</td>
<td>-2.00%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Sonoco Prods ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>Discovering Sonoco Prods: A Closer Look</h3>
<p>Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.</p>
<h3>Sonoco Prods: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Sonoco Prods showcased positive performance, achieving a revenue growth rate of <strong>30.61%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Sonoco Prods's net margin excels beyond industry benchmarks, reaching <strong>3.18%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Sonoco Prods's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.31%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Sonoco Prods's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.43%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>3.02</strong>, Sonoco Prods faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/SON/earnings"><strong>To track all earnings releases for Sonoco Prods visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Sonoco Prods's Upcoming Earnings

<p>Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Molina Healthcare will report an <strong>earnings per share</strong> (EPS) of $5.92.</p>
<p>Investors in Molina Healthcare are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.12, leading to a 5.48% drop in the share price the following trading session.</p>
<p>Here's a look at Molina Healthcare's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>5.96</td>
<td>5.88</td>
<td>5.94</td>
<td>5.55</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>6.08</td>
<td>5.05</td>
<td>6.01</td>
<td>5.86</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-5.0%</td>
<td>-10.0%</td>
<td>18.0%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210905_0.png" alt="eps graph" /></p>
<h3>Market Performance of Molina Healthcare's Stock</h3>
<p>Shares of Molina Healthcare were trading at $176.44 as of July 21. Over the last 52-week period, shares are down 37.35%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Molina Healthcare</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Molina Healthcare.</p>
<p>Analysts have given Molina Healthcare a total of 7 ratings, with the consensus rating being Neutral. The average one-year price target is $336.43, indicating a potential 90.68% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of HealthEquity, Centene and Alignment Healthcare, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for HealthEquity, with an average 1-year price target of $116.88, suggesting a potential 33.76% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Centene, with an average 1-year price target of $50.93, suggesting a potential 71.13% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Alignment Healthcare, with an average 1-year price target of $17.0, suggesting a potential 90.36% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for HealthEquity, Centene and Alignment Healthcare, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Molina Healthcare</td>
<td>Neutral</td>
<td>12.24%</td>
<td>$1.28B</td>
<td>6.77%</td>
</tr>
<tr>
<td>HealthEquity</td>
<td>Outperform</td>
<td>15.04%</td>
<td>$224.31M</td>
<td>2.54%</td>
</tr>
<tr>
<td>Centene</td>
<td>Neutral</td>
<td>15.38%</td>
<td>$5.20B</td>
<td>4.83%</td>
</tr>
<tr>
<td>Alignment Healthcare</td>
<td>Neutral</td>
<td>47.46%</td>
<td>$106.03M</td>
<td>-8.76%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Molina Healthcare ranks in the middle among peers for revenue growth. It is at the bottom for gross profit and return on equity.</p>
<h3>Get to Know Molina Healthcare Better</h3>
<p>Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.</p>
<h3>Molina Healthcare's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Molina Healthcare displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>12.24%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Molina Healthcare's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>2.67%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Molina Healthcare's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>6.77%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Molina Healthcare's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.86%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Molina Healthcare's debt-to-equity ratio is below the industry average at <strong>0.87</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/MOH/earnings"><strong>To track all earnings releases for Molina Healthcare visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Molina Healthcare

<p>Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-23. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Viking Therapeutics to report an <strong>earnings per share</strong> (EPS) of $-0.44.</p>
<p>The announcement from Viking Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.10, which was followed by a 0.5% drop in the share price the next day.</p>
<p>Here's a look at Viking Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.31</td>
<td>-0.27</td>
<td>-0.25</td>
<td>-0.27</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.41</td>
<td>-0.32</td>
<td>-0.22</td>
<td>-0.20</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-6.0%</td>
<td>21.0%</td>
<td>28.000000000000004%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210894_0.png" alt="eps graph" /></p>
<h3>Market Performance of Viking Therapeutics's Stock</h3>
<p>Shares of Viking Therapeutics were trading at $31.94 as of July 21. Over the last 52-week period, shares are down 37.15%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VKTX/earnings"><strong>To track all earnings releases for Viking Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


VKTX

A Look Ahead: Viking Therapeutics's Earnings Forecast

<p><strong>Goosehead Insurance</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Goosehead Insurance will report an <strong>earnings per share</strong> (EPS) of $0.43. </p>
<p>Goosehead Insurance bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Overview of Past Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.04, leading to a 12.0% drop in the share price on the subsequent day.</p>
<p>Here's a look at Goosehead Insurance's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.22</td>
<td>0.40</td>
<td>0.45</td>
<td>0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.26</td>
<td>0.79</td>
<td>0.50</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-12.0%</td>
<td>16.0%</td>
<td>13.0%</td>
<td>28.999999999999996%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210881_0.png" alt="eps graph" /></p>
<h3>Performance of Goosehead Insurance Shares</h3>
<p>Shares of Goosehead Insurance were trading at $101.87 as of July 21. Over the last 52-week period, shares are up 54.28%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GSHD/earnings"><strong>To track all earnings releases for Goosehead Insurance visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GSHD

A Preview Of Goosehead Insurance's Earnings

<p>Patterson-UTI Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTEN#NASDAQ">PTEN</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Patterson-UTI Energy will report an <strong>earnings per share</strong> (EPS) of $-0.03.</p>
<p>Anticipation surrounds Patterson-UTI Energy's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.04 in the last quarter, leading to a 0.16% drop in the share price on the following day.</p>
<p>Here's a look at Patterson-UTI Energy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.09</td>
<td>0.03</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>-0.13</td>
<td>0</td>
<td>0.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>0.0%</td>
<td>2.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210866_0.png" alt="eps graph" /></p>
<h3>Patterson-UTI Energy Share Price Analysis</h3>
<p>Shares of Patterson-UTI Energy were trading at $5.83 as of July 21. Over the last 52-week period, shares are down 40.58%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Opinions on Patterson-UTI Energy</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Patterson-UTI Energy.</p>
<p>A total of 7 analyst ratings have been received for Patterson-UTI Energy, with the consensus rating being Neutral. The average one-year price target stands at $7.93, suggesting a potential 36.02% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Seadrill, Helmerich &amp; Payne and Valaris, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Seadrill, with an average 1-year price target of $58.0, suggesting a potential 894.85% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Helmerich &amp; Payne, with an average 1-year price target of $20.0, suggesting a potential 243.05% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Valaris, with an average 1-year price target of $44.83, suggesting a potential 668.95% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Seadrill, Helmerich &amp; Payne and Valaris, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patterson-UTI Energy</td>
<td>Neutral</td>
<td>-15.22%</td>
<td>$87.26M</td>
<td>0.03%</td>
</tr>
<tr>
<td>Seadrill</td>
<td>Buy</td>
<td>-8.72%</td>
<td>$41M</td>
<td>-0.48%</td>
</tr>
<tr>
<td>Helmerich &amp; Payne</td>
<td>Neutral</td>
<td>47.69%</td>
<td>$156.72M</td>
<td>0.04%</td>
</tr>
<tr>
<td>Valaris</td>
<td>Neutral</td>
<td>18.23%</td>
<td>$172.60M</td>
<td>-1.71%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Patterson-UTI Energy ranks at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity.</p>
<h3>Discovering Patterson-UTI Energy: A Closer Look</h3>
<p>Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.</p>
<h3>Financial Insights: Patterson-UTI Energy</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Patterson-UTI Energy faced challenges, resulting in a decline of approximately <strong>-15.22%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> Patterson-UTI Energy's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.08%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Patterson-UTI Energy's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>0.03%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Patterson-UTI Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.02%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Patterson-UTI Energy's debt-to-equity ratio is below the industry average at <strong>0.38</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/PTEN/earnings"><strong>To track all earnings releases for Patterson-UTI Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


PTEN

Earnings Outlook For Patterson-UTI Energy

<p>4 analysts have expressed a variety of opinions on Perdoceo Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Perdoceo Education and provided 12-month price targets. The average target is $38.25, accompanied by a high estimate of $40.00 and a low estimate of $35.00. This current average reflects an increase of 3.38% from the previous average price target of $37.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210866_0_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Perdoceo Education by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Perdoceo Education. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Perdoceo Education compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Perdoceo Education's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Perdoceo Education's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PRDO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Perdoceo Education analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Delving into Perdoceo Education's Background</h2>
<p>Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.</p>
<h3>Unraveling the Financial Story of Perdoceo Education</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Perdoceo Education showcased positive performance, achieving a revenue growth rate of <strong>26.59%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Perdoceo Education's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>20.51%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>4.53%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>3.49%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Perdoceo Education's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.13</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

PRDO

4 Analysts Assess Perdoceo Education: What You Need To Know

<p>Deep-pocketed investors have adopted a bullish approach towards Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 148 extraordinary options activities for Advanced Micro Devices. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 43% leaning bullish and 43% bearish. Among these notable options, 60 are puts, totaling $3,845,890, and 88 are calls, amounting to $4,122,466.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $300.0 for Advanced Micro Devices, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Advanced Micro Devices stands at 6919.31, with a total volume reaching 1,267,243.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Advanced Micro Devices, situated within the strike price corridor from $100.0 to $300.0, throughout the last 30 days.</p>
<h3>Advanced Micro Devices Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210863_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.35</td>
<td>$7.25</td>
<td>$7.27</td>
<td>$130.00</td>
<td>$157.6K</td>
<td>12.9K</td>
<td>1.1K</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/15/26</td>
<td>$27.1</td>
<td>$27.0</td>
<td>$27.1</td>
<td>$155.00</td>
<td>$135.5K</td>
<td>304</td>
<td>57</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.9</td>
<td>$10.85</td>
<td>$10.9</td>
<td>$150.00</td>
<td>$109.0K</td>
<td>14.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/18/26</td>
<td>$34.25</td>
<td>$34.2</td>
<td>$34.25</td>
<td>$170.00</td>
<td>$102.7K</td>
<td>62</td>
<td>30</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$20.35</td>
<td>$20.25</td>
<td>$20.35</td>
<td>$170.00</td>
<td>$101.7K</td>
<td>448</td>
<td>108</td>
</tr>
</tbody>
</table>
</p>
<h3>About Advanced Micro Devices</h3>
<p>Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.</p>
<p>Following our analysis of the options activities associated with Advanced Micro Devices, we pivot to a closer look at the company's own performance.</p>
<h3>Advanced Micro Devices's Current Market Status</h3>
<ul>
<li>With a volume of 38,735,277, the price of AMD is down -1.41% at $154.78. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
<h3>What Analysts Are Saying About Advanced Micro Devices</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $176.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Advanced Micro Devices with a target price of $185.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Advanced Micro Devices, targeting a price of $175.<br />
&#x2A; Showing optimism, an analyst from HSBC upgrades its rating to Buy with a revised price target of $200.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Advanced Micro Devices, which currently sits at a price target of $145.<br />
&#x2A; Showing optimism, an analyst from Melius Research upgrades its rating to Buy with a revised price target of $175. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Advanced Micro Devices with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

Advanced Micro Devices Unusual Options Activity For July 22

<p>EastGroup Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGP#NYSE">EGP</a>) will release its quarterly earnings report on Wednesday, 2025-07-23. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate EastGroup Props to report an <strong>earnings per share</strong> (EPS) of $1.59.</p>
<p>The market awaits EastGroup Props's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS beat by $0.04 in the last quarter, leading to a 1.53% increase in the share price on the following day.</p>
<p>Here's a look at EastGroup Props's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.11</td>
<td>2.16</td>
<td>2.10</td>
<td>2.05</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.15</td>
<td>2.15</td>
<td>2.13</td>
<td>2.09</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210857_0.png" alt="eps graph" /></p>
<h3>Tracking EastGroup Props's Stock Performance</h3>
<p>Shares of EastGroup Props were trading at $165.36 as of July 21. Over the last 52-week period, shares are down 9.58%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Insights Shared by Analysts on EastGroup Props</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on EastGroup Props.</p>
<p>The consensus rating for EastGroup Props is Neutral, based on 7 analyst ratings. With an average one-year price target of $185.57, there's a potential 12.22% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Rexford Industrial Realty, Lineage and Stag Industrial, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Rexford Industrial Realty, with an average 1-year price target of $37.17, suggesting a potential 77.52% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Lineage, with an average 1-year price target of $56.5, suggesting a potential 65.83% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Stag Industrial, with an average 1-year price target of $38.0, suggesting a potential 77.02% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary presents essential metrics for Rexford Industrial Realty, Lineage and Stag Industrial, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>EastGroup Properties</td>
<td>Neutral</td>
<td>13.11%</td>
<td>$127.69M</td>
<td>1.79%</td>
</tr>
<tr>
<td>Rexford Industrial Realty</td>
<td>Neutral</td>
<td>-1.10%</td>
<td>$197.03M</td>
<td>1.31%</td>
</tr>
<tr>
<td>Lineage</td>
<td>Neutral</td>
<td>-2.71%</td>
<td>$416M</td>
<td>0.02%</td>
</tr>
<tr>
<td>Stag Industrial</td>
<td>Neutral</td>
<td>9.61%</td>
<td>$161.90M</td>
<td>2.64%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>EastGroup Properties ranks in the middle for consensus rating among its peers. It ranks at the top for revenue growth. In terms of gross profit, it is at the bottom compared to its peers. For return on equity, EastGroup Properties is at the top among its peers.</p>
<h3>Delving into EastGroup Props's Background</h3>
<p>EastGroup Properties Inc is an equity real estate investment trust. It is engaged in the development, acquisition, and operation of industrial properties in Sunbelt markets throughout the United States, predominantly in the states of Florida, Texas, Arizona, California, and North Carolina. The company manages a portfolio of industrial properties. The vast majority of these properties are multi-tenant business distribution buildings that provide large warehousing and office space for customers. The group has one reportable segment, which is industrial properties. The company derives its revenue in the form of rental income.</p>
<h3>Key Indicators: EastGroup Props's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, EastGroup Props showcased positive performance, achieving a revenue growth rate of <strong>13.11%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>34.06%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> EastGroup Props's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.79%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> EastGroup Props's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.17%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> EastGroup Props's debt-to-equity ratio is below the industry average. With a ratio of <b>0.45</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/EGP/earnings"><strong>To track all earnings releases for EastGroup Props visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Peek at EastGroup Props's Future Earnings

<p>Deep-pocketed investors have adopted a bullish approach towards Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CLF usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Cleveland-Cliffs. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 56% leaning bullish and 37% bearish. Among these notable options, 7 are puts, totaling $288,276, and 9 are calls, amounting to $445,877.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $9.0 and $15.0 for Cleveland-Cliffs, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Cleveland-Cliffs stands at 3945.57, with a total volume reaching 7,997.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cleveland-Cliffs, situated within the strike price corridor from $9.0 to $15.0, throughout the last 30 days.</p>
<h3>Cleveland-Cliffs 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210857_0_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$10.00</td>
<td>$98.0K</td>
<td>2.7K</td>
<td align="right">220</td>
</tr>
<tr>
<td>CLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/08/25</td>
<td>$0.48</td>
<td>$0.46</td>
<td>$0.48</td>
<td>$11.00</td>
<td>$96.2K</td>
<td>205</td>
<td align="right">15</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$12.00</td>
<td>$66.0K</td>
<td>3.7K</td>
<td align="right">380</td>
</tr>
<tr>
<td>CLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.25</td>
<td>$4.15</td>
<td>$4.15</td>
<td>$15.00</td>
<td>$53.1K</td>
<td>12.7K</td>
<td align="right">431</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$5.05</td>
<td>$4.8</td>
<td>$4.9</td>
<td>$10.00</td>
<td>$49.0K</td>
<td>2.7K</td>
<td align="right">320</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cleveland-Cliffs</h3>
<p>Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.</p>
<p>After a thorough review of the options trading surrounding Cleveland-Cliffs, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Cleveland-Cliffs</h3>
<ul>
<li>Currently trading with a volume of 39,902,388, the CLF's price is up by 6.61%, now at $11.37. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 104 days.</li>
</ul>
<h3>Expert Opinions on Cleveland-Cliffs</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $10.75.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JP Morgan downgraded its action to Neutral with a price target of $7.<br />
&#x2A; An analyst from Citigroup persists with their Neutral rating on Cleveland-Cliffs, maintaining a target price of $11.<br />
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Cleveland-Cliffs, targeting a price of $10.<br />
&#x2A; An analyst from Keybanc upgraded its action to Overweight with a price target of $14. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Cleveland-Cliffs, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Cleveland-Cliffs's Options: A Look at What the Big Money is Thinking

<p>6 analysts have expressed a variety of opinions on Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $166.5, with a high estimate of $190.00 and a low estimate of $130.00. This current average represents a 7.76% decrease from the previous average price target of $180.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210856_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Repligen. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Etoch</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Markowitz</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$130.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$189.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Rachel Vatnsdal</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Repligen. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Repligen compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Repligen's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Repligen's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/RGEN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Repligen analyst ratings.</strong></a></p>
<h2>Delving into Repligen's Background</h2>
<p>Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.</p>
<h3>Unraveling the Financial Story of Repligen</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Repligen's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>10.44%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Repligen's net margin excels beyond industry benchmarks, reaching <strong>3.45%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Repligen's ROE excels beyond industry benchmarks, reaching <strong>0.29%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Repligen's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.21%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Repligen's debt-to-equity ratio is below the industry average. With a ratio of <b>0.34</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RGEN

Forecasting The Future: 6 Analyst Projections For Repligen

<p>Financial giants have made a conspicuous bearish move on Morgan Stanley. Our analysis of options history for Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $167,880, and 8 were calls, valued at $334,541.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $115.0 and $150.0 for Morgan Stanley, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Morgan Stanley options trades today is 1868.38 with a total volume of 2,107.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Morgan Stanley's big money trades within a strike price range of $115.0 to $150.0 over the last 30 days.</p>
<h3>Morgan Stanley Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210852_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$11.05</td>
<td>$10.95</td>
<td>$10.95</td>
<td>$140.00</td>
<td>$116.0K</td>
<td>407</td>
<td align="right">115</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$4.8</td>
<td>$4.65</td>
<td>$4.8</td>
<td>$135.00</td>
<td>$96.0K</td>
<td>881</td>
<td align="right">500</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/15/26</td>
<td>$14.25</td>
<td>$14.05</td>
<td>$14.05</td>
<td>$140.00</td>
<td>$51.9K</td>
<td>0</td>
<td align="right">56</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$3.5</td>
<td>$3.45</td>
<td>$3.5</td>
<td>$125.00</td>
<td>$51.8K</td>
<td>607</td>
<td align="right">194</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$6.2</td>
<td>$6.15</td>
<td>$6.15</td>
<td>$150.00</td>
<td>$40.5K</td>
<td>5.1K</td>
<td align="right">71</td>
</tr>
</tbody>
</table>
</p>
<h3>About Morgan Stanley</h3>
<p>Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the great financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.</p>
<h3>Current Position of Morgan Stanley</h3>
<ul>
<li>Trading volume stands at 2,847,811, with MS's price up by 0.05%, positioned at $140.54.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 85 days.</li>
</ul>
<h3>Expert Opinions on Morgan Stanley</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $152.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Keefe, Bruyette &amp; Woods has elevated its stance to Outperform, setting a new price target at $160.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Morgan Stanley with a target price of $145. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Morgan Stanley, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Morgan Stanley Unusual Options Activity

<p>In the last three months, 4 analysts have published ratings on Integral Ad Science Holdi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.75, a high estimate of $14.00, and a low estimate of $9.00. This current average is unchanged from the previous average price target. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210845_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of Integral Ad Science Holdi among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Andrew Marok</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Andrew Marok</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$11.00</td>
<td>$16.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Integral Ad Science Holdi. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Integral Ad Science Holdi compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Integral Ad Science Holdi's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Integral Ad Science Holdi's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/IAS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Integral Ad Science Holdi analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Get to Know Integral Ad Science Holdi Better</h2>
<p>Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.</p>
<h3>Integral Ad Science Holdi: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Integral Ad Science Holdi displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>17.06%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Communication Services sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Integral Ad Science Holdi's net margin excels beyond industry benchmarks, reaching <strong>5.96%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Integral Ad Science Holdi's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>0.78%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.7%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Integral Ad Science Holdi's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.04</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


4 Analysts Assess Integral Ad Science Holdi: What You Need To Know

<p><strong>Estee Lauder Cos's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) short percent of float has risen 43.16% since its last report. The company recently reported that it has <strong>14.34 million shares sold short</strong>, which is 6.17% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.34 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Estee Lauder Cos Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210834_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Estee Lauder Cos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Estee Lauder Cos's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Estee Lauder Cos's peer group average for short interest as a percentage of float is 6.98%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

Peering Into Estee Lauder Cos's Recent Short Interest

<p>In the preceding three months, 5 analysts have released ratings for Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Federal Signal, revealing an average target of $102.0, a high estimate of $120.00, and a low estimate of $84.00. This current average has increased by 12.71% from the previous average price target of $90.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210833_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Federal Signal. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Shlisky</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Tim Thein</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Shlisky</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$96.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Steve Barger</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Shlisky</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$84.00</td>
<td>$82.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Federal Signal. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Federal Signal compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Federal Signal's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Federal Signal's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FSS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Federal Signal analyst ratings.</strong></a></p>
<h2>Discovering Federal Signal: A Closer Look</h2>
<p>Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.</p>
<h3>Financial Insights: Federal Signal</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Federal Signal displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>9.16%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> Federal Signal's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>9.98%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Federal Signal's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>3.88%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Federal Signal's ROA excels beyond industry benchmarks, reaching <strong>2.54%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Federal Signal's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.25</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What Analysts Are Saying About Federal Signal Stock

<p><strong>Insulet's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NYSE">PODD</a>) short percent of float has risen 16.26% since its last report. The company recently reported that it has <strong>2.21 million shares sold short</strong>, which is 4.79% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.61 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Insulet Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753210828_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Insulet has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Insulet's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Insulet's peer group average for short interest as a percentage of float is 4.14%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Comments

Alibaba Gr Hldgs

Intérêt court

Alibaba Gr Hldgs (OTC:BABAF) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL